These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34561270)

  • 61. Glioblastoma Immune Landscape and the Potential of New Immunotherapies.
    Daubon T; Hemadou A; Romero Garmendia I; Saleh M
    Front Immunol; 2020; 11():585616. PubMed ID: 33154756
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunotherapy advances for glioblastoma.
    Reardon DA; Freeman G; Wu C; Chiocca EA; Wucherpfennig KW; Wen PY; Fritsch EF; Curry WT; Sampson JH; Dranoff G
    Neuro Oncol; 2014 Nov; 16(11):1441-58. PubMed ID: 25190673
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeted Therapies for the Treatment of Glioblastoma in Adults.
    Chuang DF; Lin X
    Curr Oncol Rep; 2019 May; 21(7):61. PubMed ID: 31102038
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prospects of immune checkpoint modulators in the treatment of glioblastoma.
    Preusser M; Lim M; Hafler DA; Reardon DA; Sampson JH
    Nat Rev Neurol; 2015 Sep; 11(9):504-14. PubMed ID: 26260659
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glioblastoma-derived mechanisms of systemic immunosuppression.
    Waziri A
    Neurosurg Clin N Am; 2010 Jan; 21(1):31-42. PubMed ID: 19944964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunotherapy for Glioblastoma: Current Progress and Challenges.
    Yu MW; Quail DF
    Front Immunol; 2021; 12():676301. PubMed ID: 34054867
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
    Bambury RM; Morris PG
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Using viral vectors to deliver local immunotherapy to glioblastoma.
    Haddad AF; Young JS; Aghi MK
    Neurosurg Focus; 2021 Feb; 50(2):E4. PubMed ID: 33524947
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ipilimumab: an investigational immunotherapy for glioblastoma.
    Youssef G; Dietrich J
    Expert Opin Investig Drugs; 2020 Nov; 29(11):1187-1193. PubMed ID: 32945231
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside.
    Li Y; Sharma A; Maciaczyk J; Schmidt-Wolf IGH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163235
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
    Goswami S; Walle T; Cornish AE; Basu S; Anandhan S; Fernandez I; Vence L; Blando J; Zhao H; Yadav SS; Ott M; Kong LY; Heimberger AB; de Groot J; Sepesi B; Overman M; Kopetz S; Allison JP; Pe'er D; Sharma P
    Nat Med; 2020 Jan; 26(1):39-46. PubMed ID: 31873309
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
    Choi BD; Maus MV; June CH; Sampson JH
    Clin Cancer Res; 2019 Apr; 25(7):2042-2048. PubMed ID: 30446589
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma.
    Zhao B; Wu J; Li H; Wang Y; Wang Y; Xing H; Wang Y; Ma W
    Cell Commun Signal; 2023 Apr; 21(1):74. PubMed ID: 37046332
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The current and future aspects of glioblastoma: Immunotherapy a new hope?
    Patel V; Shah J
    Eur J Neurosci; 2021 Aug; 54(3):5120-5142. PubMed ID: 34107127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Investigational treatment strategies in glioblastoma: progress made and barriers to success.
    Nelson TA; Dietrich J
    Expert Opin Investig Drugs; 2023; 32(10):921-930. PubMed ID: 37796104
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Emerging therapies for glioblastoma: current state and future directions.
    Rong L; Li N; Zhang Z
    J Exp Clin Cancer Res; 2022 Apr; 41(1):142. PubMed ID: 35428347
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treating recurrent glioblastoma: an update.
    Kamiya-Matsuoka C; Gilbert MR
    CNS Oncol; 2015; 4(2):91-104. PubMed ID: 25768333
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
    Eder K; Kalman B
    Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prolonged response of recurrent
    Hwang H; Huang J; Khaddour K; Butt OH; Ansstas G; Chen J; Katumba RG; Kim AH; Leuthardt EC; Campian JL
    CNS Oncol; 2022 Mar; 11(1):CNS81. PubMed ID: 35043686
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vaccination in the immunotherapy of glioblastoma.
    Kong Z; Wang Y; Ma W
    Hum Vaccin Immunother; 2018 Feb; 14(2):255-268. PubMed ID: 29087782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.